D: +44 (0) 208 759 3411 Ext. 111
Email: PCC.ROW@piramal.com
For Medical Information queries, contact: medical.information@piramal.com.
Report a complaint about a product, vaporizer, or other matter.
Adverse events should be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints
Piramal Critical Care B.V.
Register No :- 70138869
Business Address
Rouboslaan 32 (ground floor), 2252 TR
Voorschoten
The Netherlands
Telephone: +31712034050 / Fax No. +31712034052
Email: Pcc.Netherlands@Piramal.com
For Medical Information queries, contact: medical.information@piramal.com.
Report a complaint about a product, vaporizer, or other matter.
Adverse events should be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints
D: +44 (0) 208 759 3411 Ext. 111
Email: PCC.ROW@piramal.com
For Medical Information queries, contact: medical.information@piramal.com.
Report a complaint about a product, vaporizer, or other matter.
Adverse events should be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints
Phone: +971509414333
Email: PCC.ROW@piramal.com
For Medical Information queries, contact: medical.information@piramal.com.
Report a complaint about a product, vaporizer, or other matter.
Adverse events should be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints
Phone: +39 045 8753 281
Email: PCC.ROW@piramal.com
For Medical Information queries, contact: medical.information@piramal.com.
Report a complaint about a product, vaporizer, or other matter.
Adverse events should be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints
For Financial & Legal Information on Piramal Critical Care – Greece, please click here.
Phone: +33 (0)6 14 81 26 33
Email: PCC.ROW@piramal.com
The company Centre Spécialités Pharmaceutiques (CSP) is responsible for Exploitant activities on behalf of Piramal Critical Care Limited and CSP monitors pharmacovigilance and medical information: any adverse reactions related to PCC pharmaceutical specialities and medical questions relating to these products must be reported to CSP’s Pharmacovigilance Department.
Telephone: +33 1 47 04 80 46 (open 24 hours a day)
Mail: infomed_pv@csp-epl.com
D: +44 (0) 208 759 3411 Ext. 111
Email: PCC.ROW@piramal.com
For Medical Information queries, contact: medical.information@piramal.com.
Report a complaint about a product, vaporizer, or other matter.
Adverse events should be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints
Phone: +971509414333
Email: PCC.ROW@piramal.com
For Medical Information queries, contact: medical.information@piramal.com.
Report a complaint about a product, vaporizer, or other matter.
Adverse events should be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints
Pro shrnuti charakteristiky produktu Dipidolor a informační brožuru o pacientovi, klikněte zde
Pro shrnuti charakteristiky produktu Hypnomidate a informační brožuru o pacientovi, klikněte zde
Pro shrnuti charakteristiky produktu Rapifen a informační brožuru o pacientovi, klikněte zde
Pro shrnuti charakteristiky produktu Sojourn a informační brožuru o pacientovi, klikněte zde
Pro shrnuti charakteristiky produktu Sufenta a informační brožuru o pacientovi, klikněte zde
Pro shrnuti charakteristiky produktu Sufenta Forte a informační brožuru o pacientovi, klikněte zde
Kontaktní osoba:
Telefon: +971509414333
E-mailem: PCC.ROW@piramal.com
Pro podání stížnosti, klikněte zde
Phone: +971509414333
Email: PCC.ROW@piramal.com
For Medical Information queries, contact: medical.information@piramal.com.
Report a complaint about a product, vaporizer, or other matter.
Adverse events should be reported to Piramal Critical Care at https://piramalcriticalcare.com/complaints